Last Posted: Sep 26, 2019
- Better Genetic Testing Guidelines Needed to Identify More At-Risk Patients
Managed Care Executive, September 25, 2019 - Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.
Ndugga-Kabuye Mesaki K et al. Familial cancer 2019 Sep - Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
Casasanta Nicole et al. Clinical breast cancer 2019 Aug - Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Greenberg Samantha et al. Cancer medicine 2019 Sep - STELO: a new tool for family physicians for the correct identification of inherited cancer syndromes.
Mariani Chiara et al. Family practice 2019 Sep - Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study.
Rashid Muhammad Usman et al. Hereditary cancer in clinical practice 2019 1727 - Should You Get Genetic Testing for Cancer Risk?
American Cancer Society, September 18, 2019 - Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.
Dumbrava E Ileana et al. JCO precision oncology 2019 3 - Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
Snowsill Tristan M et al. PloS one 2019 14(8) e0221419 - Universal Genetic Testing for All Breast Cancer Patients.
Copur Mehmet Sitki et al. Oncology (Williston Park, N.Y.) 2019 Aug 33(8)
No comments:
Post a Comment